William Longley – CEO and Founder
Bill started Scientific Intake with a patent license, a device mockup, and the belief that slowing food intake with smaller bites at the gateway to the body would help people lose weight safely.
After an enthusiastic response from a half dozen obesity experts, he funded a clinical study that confirmed the hypothesis- device users were satisfied with 23% less food than non-users. The study was peer-reviewed and published in Obesity. Money was raised and product development began. Over the years, device improvements were made, manufacturing methods evolved, he invented the embedded microsensor and app, more marketing and clinical research studies were completed and U.S. and international regulatory approvals were achieved.
Since then, telemedicine has become mainstream for prescribing pharmaceuticals and devices. New oral imaging technology and manufacturing techniques have cut costs and improved efficiency. And, over the past six months, the success of the newly injected compounds to control appetite has proven that hormones are the key to significant weight loss.
The SmartByte device, which activates the body’s natural hunger and satiety hormones, is in the right place at the right time. Bill realizes that properly introducing SmartByte is beyond Scientific Intake’s expertise and funding capabilities, so he is now leading the search for the best company to launch our innovative solution.
Prior to starting Scientific Intake, Bill was the co-founder and Vice Chairman of Medcast, an internet physician news and information service that was acquired by WebMD in 1999 for $215mm. Before Medcast, he founded the Health Monitor Network which grew to over 10,000 blood pressure kiosks in major chain pharmacies sponsored by leading life sciences companies. He began his career at college magazine publisher 13-30 Corporation where his performance was rewarded with stock. 13-30 acquired Esquire magazine in 1979 where Bill advanced to V.P. Group Ad Director and ultimately Group Publisher. His contributions were instrumental in the sale of Esquire to Hearst in 1986. He is a graduate of the University of Arizona.
Richard Schneider – Chief Operating Officer
Richard P. Schneider is a Board member, senior executive and management advisor with experience in governance, operations, corporate development, strategic planning, venture capital and private equity. He has an extensive knowledge base in a variety of industrial and consumer businesses. His corporate management and investing careers have focused on developing strategies and managing organizations at the senior level for growth and value creation.
Dick has been a key advisor since the Scientific Intake was founded. In 2012 he became the Chief Operating Officer and Chief Financial Officer. He has been a member of the Board of Directors since 2010 and currently serves as Chairman. Prior to Scientific Intake, Dick was a founding general partner of New York-based Easton Capital Investment Group, which managed more than $300-million through five diversified venture and expansion capital funds. He had been involved as a principal investor in venture capital private equity transactions since joining the funds’ predecessor, Easton Capital Corp., in 1997. His primary areas of focus with regard to the Easton investment portfolio were in semiconductors, life sciences, industrial processes and consumer products. He served as COO/CFO of the Easton Group from 2000-2012.
Before joining Easton Capital, Dick spent 15 years as a corporate M&A and Strategy executive, advising operating managers on competitive and growth strategies, and initiating, negotiating and closing more than $1.4 billion in acquisitions and divestitures of domestic and international businesses in a wide variety of industries.
From 1993 to 1997 he was Vice President of Corporate Development at Handy & Harman, a diversified industrial NYSE company, where he was responsible for the rapid growth through strategic acquisitions of the Handy & Harman Electronic Materials Group. From 1985 to 1993 he was Vice President, Planning & Development at Sequa Corp. (also NYSE and formerly Sun Chemical). He received an MBA degree from Harvard Business School, a BS in Mechanical Engineering and an AB (English Literature) degrees both from Princeton University.
In addition to Scientific Intake, Dick serves on the Boards of Achronix Semiconductor and Aspen Avionics. He is also Chairman of the Board of New Mexico Community Capital, a non-profit focused on fostering and facilitating economic development in the Native American communities of the Southwest and Midwest.
Donna Ryan M.D. MABOM, FTOS – Lead Scientific Advisor
Donna Ryan M.D. is Professor Emerita at Pennington Biomedical in Baton Rouge, LA, USA where she had a 25-year career in clinical research in obesity. She was an Investigator on POUNDS Lost, Look AHEAD, DPP, DASH and many other studies of the health benefits of weight loss by diet, lifestyle intervention and medications. She was PI of a series of studies over 25 years funded by the US Department of Defense targeting military nutrition. Her personal research studied improving primary care management of obesity. She has been an active member and former President of The Obesity Society (USA) and World Obesity Federation. Currently Dr. Ryan serves as Co-Chair of the SELECT Steering Committee and member of the Data Safety Monitoring Boards for setmelanotide and retatrutide. She has more than 300 publications, is an frequent speaker on obesity and diabetes treatments and remains an active consultant and advisor to companies developing drugs, devices, lifestyle programs and medical approaches to obesity management.
Sandy Romoser – Strategy and M&A Consulting
Sandy is an accomplished senior executive leader with a successful track record of leading multi-billion-dollar, global businesses for fortune 50 companies. She is a respected change agent who boldly challenges the status quo, identifies visionary opportunities, and champions initiatives that drive transformational business and cultural success.
Sandy has a broad set of career experiences that includes Board of Directors collaboration, international business operations, mergers & acquisitions, financial planning & reporting, corporate strategy, governance and risk management, product development, manufacturing, logistics & operations, marketing, ecommerce, communications, organizational development, and sales.
Sandy recently retired from the position of President & CEO, Guest Worldwide. Guest Worldwide is a $1B+ leading global provider of products to the hospitality/travel, healthcare, and business & industry channels, as well as direct to consumer. Guest Worldwide operates in the U.S. Canada, Europe, Asia, and the Middle East and is the parent company for three businesses, Gilchrist & Soames, a personal care products manufacturer, Manchester Mills, a textile manufacturer, and Guest Supply, a non-perishables broadline distributor.
Prior to joining Guest Worldwide, Sandy had a 16-year career with PepsiCo, where she most recently served as Senior Vice-President and Global Chief Customer Officer for PepsiCo’s $7B Foodservice Division. In this role she led strategic customer partnerships, industry relations, strategy, product innovation, and marketing.
Sandy is an authentic leader and bold thinker, being tapped several times in her career to develop and lead difficult or delicate transformations, turnarounds and merger and acquisition efforts.
Scott Huge – Manufacturing Advisor
Scott has spent his entire career in the oral device industry. He founded Specialty Appliances in 1981 which has grown into one of the largest manufacturers of oral devices in the U.S. As one of the foremost experts on prototype development and efficient fabrication techniques for individualized oral devices, Scientific Intake began a relationship with Scott early on. Using feedback from SmartByte users, Scott’s creativity combined with knowledge of fabrication and materials resulted in improvements for comfort, ease of use, durability and the manufacturing process. With Scott’s help, Smartbyte has evolved our patents and trade secrets over the years into the de novo device cleared by the FDA. More recently, Scott and his team have led the industry in adopting new technologies such as digital oral scanning, computer designed devices and 3D printing in biocompatible materials, all of which take time and costs out of the manufacturing process.
Katherine O’Hara – Lead Marketing Advisor
Katherine O’Hara is the founder of The O’Hara Project, an integrated marketing firm that offers marketing, public relations, social media, and ideation services to a wide range of clients, including Fortune 500 companies, non-profits, and emerging entities. With national and global experience in building brands, Katherine has received over 200 industry and business awards, including Businesswoman of the Year by the Morris County Hispanic Chamber of Commerce, a 40 Under 40 Winner by NJBIZ, the Penn State Distinguished Alumni Award, and recognition as a Top 25 Leading Women Entrepreneur by LWE.